Novo Holdings A/S - Q2 2018 holdings

Add to watchlist

$995 Million is the total value of Novo Holdings A/S's 19 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 23.5% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
INGN  INOGEN INC$661,345,000
+51.7%
3,549,3200.0%66.50%
+21.6%
XLRN SellACCELERON PHARMA INC$53,563,000
-11.8%
1,103,937
-29.0%
5.39%
-29.3%
CRVS  CORVUS PHARMACEUTICALS INC$48,537,000
-4.8%
4,420,5160.0%4.88%
-23.7%
MRUS  MERUS N V$32,101,000
+22.8%
1,410,4170.0%3.23%
-1.5%
AKBA  AKEBIA THERAPEUTICS INC$30,938,000
+4.7%
3,100,0000.0%3.11%
-16.0%
GKOS BuyGLAUKOS CORP$24,494,000
+40.6%
602,709
+6.6%
2.46%
+12.7%
DERM  DERMIRA INC$18,342,000
+15.1%
1,993,7460.0%1.84%
-7.7%
KIDS BuyORTHOPEDIATRICS CORP$17,405,000
+85.0%
653,349
+4.6%
1.75%
+48.3%
FOLD NewAMICUS THERAPEUTICS INC$16,888,000–1,081,181
+100.0%
1.70%–
RARX  RA PHARMACEUTICALS INC$14,585,000
+87.4%
1,465,8380.0%1.47%
+50.2%
SPNE BuySEASPINE HLDGS CORP$11,709,000
+25.5%
927,788
+0.8%
1.18%
+0.6%
MNLO BuyMENLO THERAPEUTICS INC$11,663,000
-77.2%
1,436,313
+5.5%
1.17%
-81.7%
VRNA  VERONA PHARMA PLCsponsored ads$10,119,000
-31.7%
740,7400.0%1.02%
-45.3%
SellNABRIVA THERAPEUTICS PLC$10,053,000
-31.7%
2,888,720
-1.2%
1.01%
-45.2%
UMRX  UNUM THERAPEUTICS INC$9,545,000
-69.9%
665,1810.0%0.96%
-75.8%
AERI NewAERIE PHARMACEUTICALS INC$8,538,000–126,397
+100.0%
0.86%–
WMGIZ  WRIGHT MED GROUP N Vright 03/01/2019$5,916,000
-6.6%
4,622,0320.0%0.60%
-25.1%
IVTY  INVUITY INC$5,319,000
+1.3%
1,363,8480.0%0.54%
-18.7%
C NewCITIGROUP INC$3,513,000–52,500
+100.0%
0.35%–
CRSP ExitCRISPR THERAPEUTICS AGnamen akt$0–-223,317
-100.0%
-1.28%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-14
  • View 13F-HR/A filed 2019-02-06
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS41Q3 202264.7%
INOGEN INC34Q2 202268.8%
VANGUARD INTL EQUITY INDEX F29Q4 201637.6%
AMICUS THERAPEUTICS INC22Q3 20234.1%
AKEBIA THERAPEUTICS INC21Q3 20204.8%
VERONA PHARMA PLC21Q2 20221.9%
CORVUS PHARMACEUTICALS INC20Q4 20207.1%
INSPIRE MED SYS INC20Q3 20231.8%
CABLE ONE INC19Q3 20239.7%
FLEXION THERAPEUTICS INC19Q3 20214.7%

View Novo Holdings A/S's complete holdings history.

Latest significant ownerships (13-D/G)
Novo Holdings A/S Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%

View Novo Holdings A/S's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-03-28
42024-03-25
SC 13D/A2024-03-25
42024-03-20
SC 13D/A2024-03-20
1442024-03-18
42024-03-18
SC 13D/A2024-03-18
1442024-03-14
SC 13D/A2024-03-07

View Novo Holdings A/S's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been amended

Export Novo Holdings A/S's holdings

CSVXLS